glp 1 heart racing GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies How GLP-1 Medications Reduce Heart

Obesity and cardiovascular disease: a scientific statement from the American heart association

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH

Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

The Food Industry Is Already Feeling the Impact The growing use of GLP-1 drugs beyond diabetes management is even gaining the attention of the food and beverage industry

39 showed that peripherally injected GLP-1 rapidly enters the brain through endothelial cells